PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY ROA • Market segmentation by RoA • Comparison by RoA • Parenteral - Market size and forecast 2018-2023 • Topical - Market size and forecast 2018-2023 • Market opportunity by RoA PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2018-2023 • Europe - Market size and forecast 2018-2023 • Asia - Market size and forecast 2018-2023 • ROW - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 09: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 10: MARKET TRENDS PART 11: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive scenario PART 12: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • ALLERGAN • Bausch Health • GlaxoSmithKline plc. • Lee's Pharmaceutical Holdings Limited • Merck Sharp & Dohme Corp. PART 13: APPENDIX • Research methodology • List of abbreviations Exhibit 01: Years in consideration Exhibit 02: Global pharmaceuticals market Exhibit 03: Segments of global pharmaceuticals market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: RoA - Market share 2018-2023 (%) Exhibit 19: Comparison by RoA Exhibit 20: Parenteral - Market size and forecast 2018-2023 ($ millions) Exhibit 21: Parenteral - Year-over-year growth 2019-2023 (%) Exhibit 22: Topical - Market size and forecast 2018-2023 ($ millions) Exhibit 23: Topical - Year-over-year growth 2019-2023 (%) Exhibit 24: Market opportunity by RoA Exhibit 25: Customer landscape Exhibit 26: Market share by geography 2018-2023 (%) Exhibit 27: Geographic comparison Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 29: North America - Year-over-year growth 2019-2023 (%) Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 31: Europe - Year-over-year growth 2019-2023 (%) Exhibit 32: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 33: Asia - Year-over-year growth 2019-2023 (%) Exhibit 34: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 35: ROW - Year-over-year growth 2019-2023 (%) Exhibit 36: Key leading countries Exhibit 37: Market opportunity Exhibit 38: Decision framework Exhibit 39: Impact of drivers and challenges Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: ALLERGAN - Vendor overview Exhibit 46: ALLERGAN - Product segments Exhibit 47: ALLERGAN - Organizational developments Exhibit 48: ALLERGAN - Geographic focus Exhibit 49: ALLERGAN - Segment focus Exhibit 50: ALLERGAN - Key offerings Exhibit 51: ALLERGAN - Key customers Exhibit 52: Bausch Health - Vendor overview Exhibit 53: Bausch Health - Product segments Exhibit 54: Bausch Health - Organizational developments Exhibit 55: Bausch Health - Geographic focus Exhibit 56: Bausch Health - Segment focus Exhibit 57: Bausch Health - Key offerings Exhibit 58: Bausch Health - Key customers Exhibit 59: GlaxoSmithKline plc. - Vendor overview Exhibit 60: GlaxoSmithKline plc. - Business segments Exhibit 61: GlaxoSmithKline plc. - Organizational developments Exhibit 62: GlaxoSmithKline plc. - Geographic focus Exhibit 63: GlaxoSmithKline plc. - Segment focus Exhibit 64: GlaxoSmithKline plc. - Key offerings Exhibit 65: GlaxoSmithKline plc. - Key customers Exhibit 66: Lee's Pharmaceutical Holdings Limited - Vendor overview Exhibit 67: Lee's Pharmaceutical Holdings Limited - Business segments Exhibit 68: Lee's Pharmaceutical Holdings Limited - Organizational developments Exhibit 69: Lee's Pharmaceutical Holdings Limited - Segment focus Exhibit 70: Lee's Pharmaceutical Holdings Limited - Key offerings Exhibit 71: Lee's Pharmaceutical Holdings Limited - Key customers Exhibit 72: Merck Sharp & Dohme Corp. - Vendor overview Exhibit 73: Merck Sharp & Dohme Corp. - Business segments Exhibit 74: Merck Sharp & Dohme Corp. - Organizational developments Exhibit 75: Merck Sharp & Dohme Corp. - Geographic focus Exhibit 76: Merck Sharp & Dohme Corp. - Segment focus Exhibit 77: Merck Sharp & Dohme Corp. - Key offerings Exhibit 78: Merck Sharp & Dohme Corp. - Key customers Exhibit 79: Validation techniques employed for market sizing Exhibit 80: List of abbreviations  

ALLERGAN Bausch Health GlaxoSmithKline Lee's Pharmaceutical Holdings Merck Sharp & Dohme